(3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

C132H205Br2F9O8 — CID 158076977

About (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol (PubChem CID 158076977) has the molecular formula C132H205Br2F9O8 and a molecular weight of 2250.87 g/mol. Its IUPAC name is (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol.

Molecular Properties

• Compound Name: (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
• PubChem CID: 158076977
• Molecular Formula: C132H205Br2F9O8
• Molecular Weight: 2250.87 g/mol
• Exact Mass: 2247.39
• IUPAC Name: (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
• SMILES: C=C(C)[C@H]1CC[C@H]2[C@@H]3CC(F)(F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CBr)[C@H]1CC[C@H]2[C@@H]3CC(F)(F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CBr)[C@H]1CC[C@H]2[C@@H]3C[C@@H](F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CO)[C@H]1CC[C@H]2[C@@H]3CC(F)(F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CO)[C@H]1CC[C@H]2[C@@H]3C[C@@H](F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C
• InChI: InChI=1S/C22H33BrF2O.C22H34BrFO.C22H34F2O2.C22H34F2O.C22H35FO2.C22H35FO/c1-13(12-23)17-4-5-18-16-10-22(24,25)19-11-20(2,26)8-6-15(19)14(16)7-9-21(17,18)3;1-13(12-23)18-4-5-19-16-10-20(24)17-11-21(2,25)8-6-15(17)14(16)7-9-22(18,19)3;1-13(12-25)17-4-5-18-16-10-22(23,24)19-11-20(2,26)8-6-15(19)14(16)7-9-21(17,18)3;1-13(2)17-5-6-18-16-11-22(23,24)19-12-20(3,25)9-7-15(19)14(16)8-10-21(17,18)4;1-13(12-24)18-4-5-19-16-10-20(23)17-11-21(2,25)8-6-15(17)14(16)7-9-22(18,19)3;1-13(2)18-5-6-19-16-11-20(23)17-12-21(3,24)9-7-15(17)14(16)8-10-22(18,19)4/h14-19,26H,1,4-12H2,2-3H3;14-20,25H,1,4-12H2,2-3H3;14-19,25-26H,1,4-12H2,2-3H3;14-19,25H,1,5-12H2,2-4H3;14-20,24-25H,1,4-12H2,2-3H3;14-20,24H,1,5-12H2,2-4H3/t14-,15-,16-,17-,18+,19-,20+,21-;14-,15-,16-,17-,18-,19+,20-,21+,22-;2*14-,15-,16-,17-,18+,19-,20+,21-;2*14-,15-,16-,17-,18-,19+,20-,21+,22-/m111111/s1
• InChIKey: FMMKVUSMSBTVHU-PSGDFQMLSA-N
• XLogP: 32.77
• TPSA: 161.84 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 8
• Rotatable Bonds: 10
• Heavy Atoms: 151
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2250.87
LogP ≤ 5	32.77
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	8

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?

The IUPAC name of (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol (CID 158076977) is (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol.

What is the SMILES notation for (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?

The canonical SMILES for (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol is C=C(C)[C@H]1CC[C@H]2[C@@H]3CC(F)(F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CBr)[C@H]1CC[C@H]2[C@@H]3CC(F)(F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CBr)[C@H]1CC[C@H]2[C@@H]3C[C@@H](F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CO)[C@H]1CC[C@H]2[C@@H]3CC(F)(F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.C=C(CO)[C@H]1CC[C@H]2[C@@H]3C[C@@H](F)[C@@H]4C[C@@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C.

What is the InChIKey of (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?

The InChIKey is FMMKVUSMSBTVHU-PSGDFQMLSA-N. The full InChI is InChI=1S/C22H33BrF2O.C22H34BrFO.C22H34F2O2.C22H34F2O.C22H35FO2.C22H35FO/c1-13(12-23)17-4-5-18-16-10-22(24,25)19-11-20(2,26)8-6-15(19)14(16)7-9-21(17,18)3;1-13(12-23)18-4-5-19-16-10-20(24)17-11-21(2,25)8-6-15(17)14(16)7-9-22(18,19)3;1-13(12-25)17-4-5-18-16-10-22(23,24)19-11-20(2,26)8-6-15(19)14(16)7-9-21(17,18)3;1-13(2)17-5-6-18-16-11-22(23,24)19-12-20(3,25)9-7-15(19)14(16)8-10-21(17,18)4;1-13(12-24)18-4-5-19-16-10-20(23)17-11-21(2,25)8-6-15(17)14(16)7-9-22(18,19)3;1-13(2)18-5-6-19-16-11-20(23)17-12-21(3,24)9-7-15(17)14(16)8-10-22(18,19)4/h14-19,26H,1,4-12H2,2-3H3;14-20,25H,1,4-12H2,2-3H3;14-19,25-26H,1,4-12H2,2-3H3;14-19,25H,1,5-12H2,2-4H3;14-20,24-25H,1,4-12H2,2-3H3;14-20,24H,1,5-12H2,2-4H3/t14-,15-,16-,17-,18+,19-,20+,21-;14-,15-,16-,17-,18-,19+,20-,21+,22-;2*14-,15-,16-,17-,18+,19-,20+,21-;2*14-,15-,16-,17-,18-,19+,20-,21+,22-/m111111/s1.

What are the key properties of (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol?

(3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol has a molecular weight of 2250.87 g/mol, XLogP of 32.77, 10 rotatable bonds, 8 hydrogen bond donors, and 8 hydrogen bond acceptors.

Where does this data come from?

All data for (3S,5R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6,6-difluoro-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-17-(3-bromoprop-1-en-2-yl)-6-fluoro-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17R)-6,6-difluoro-3,13-dimethyl-17-prop-1-en-2-yl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,8R,9S,10R,13S,14S,17S)-6,6-difluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-1,2,4,5,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17R)-6-fluoro-3,13-dimethyl-17-prop-1-en-2-yl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,5R,6R,8R,9S,10R,13S,14S,17S)-6-fluoro-17-(3-hydroxyprop-1-en-2-yl)-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 158076977), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).